Vijaya Diagnostic Centre Limited (VIJAYA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.160x

Based on the latest financial reports, Vijaya Diagnostic Centre Limited (VIJAYA) has a cash flow conversion efficiency ratio of 0.160x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.39 Billion ≈ $14.99 Million USD) by net assets (Rs8.65 Billion ≈ $93.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Vijaya Diagnostic Centre Limited defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Vijaya Diagnostic Centre Limited - Cash Flow Conversion Efficiency Trend (2019–2026)

This chart illustrates how Vijaya Diagnostic Centre Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Vijaya Diagnostic Centre Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vijaya Diagnostic Centre Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Shenzhen Laibao High-Technology Co Ltd
SHE:002106
0.017x
Hefei Jianghang Aircraft Equipment Corporation Ltd
SHG:688586
-0.030x
Kosmos Energy Ltd
NYSE:KOS
0.207x
Telecom Argentina SA ADR
NYSE:TEO
0.093x
Yinson Holdings Bhd
KLSE:7293
0.121x
Zhejiang Huatie Constr Safety
SHG:603300
0.167x
Pci-Suntek Technology Co Ltd
SHG:600728
0.008x
TGS ASA SP.ADR/1
F:TGC0
0.129x

Annual Cash Flow Conversion Efficiency for Vijaya Diagnostic Centre Limited (2019–2026)

The table below shows the annual cash flow conversion efficiency of Vijaya Diagnostic Centre Limited from 2019 to 2026. For the full company profile with market capitalisation and key ratios, see VIJAYA market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs9.57 Billion
≈ $103.51 Million
Rs2.71 Billion
≈ $29.26 Million
0.283x +0.65%
2025-03-31 Rs7.99 Billion
≈ $86.42 Million
Rs2.24 Billion
≈ $24.28 Million
0.281x +1.13%
2024-03-31 Rs6.60 Billion
≈ $71.37 Million
Rs1.83 Billion
≈ $19.82 Million
0.278x -7.76%
2023-03-31 Rs5.47 Billion
≈ $59.12 Million
Rs1.65 Billion
≈ $17.80 Million
0.301x -10.51%
2022-03-31 Rs4.70 Billion
≈ $50.78 Million
Rs1.58 Billion
≈ $17.09 Million
0.336x -6.76%
2021-03-31 Rs3.59 Billion
≈ $38.85 Million
Rs1.30 Billion
≈ $14.02 Million
0.361x -6.76%
2020-03-31 Rs2.74 Billion
≈ $29.65 Million
Rs1.06 Billion
≈ $11.48 Million
0.387x -11.49%
2019-03-31 Rs2.07 Billion
≈ $22.39 Million
Rs905.27 Million
≈ $9.79 Million
0.437x --

About Vijaya Diagnostic Centre Limited

NSE:VIJAYA India Diagnostics & Research
Market Cap
$1.45 Billion
Rs134.34 Billion INR
Market Cap Rank
#7507 Global
#360 in India
Share Price
Rs1305.60
Change (1 day)
+0.47%
52-Week Range
Rs861.40 - Rs1372.40
All Time High
Rs1372.40
About

Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T ser… Read more